{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:27:28Z","timestamp":1740144448089,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Turkish Society for Radiation Oncology","award":["APDP-TROD-2019-2"],"award-info":[{"award-number":["APDP-TROD-2019-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11547-020-01187-x","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T12:02:26Z","timestamp":1586520146000},"page":"981-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is there any correlation between HPV and early radioresponse before brachytherapy in cervix uteri carcinoma?"],"prefix":"10.1007","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-3694","authenticated-orcid":false,"given":"Binnur D\u00f6nmez","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-4304","authenticated-orcid":false,"given":"Emre","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-3436","authenticated-orcid":false,"given":"Necla","family":"Gurdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-3495","authenticated-orcid":false,"given":"Alper","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"issue":"6","key":"1187_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jamel A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"1187_CR2","unstructured":"Turkey Cancer Statistics (2014) Ministry of Health Agency of Cancer Department. https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/kanser-db\/istatistik\/2014-RAPOR._uzuuun.pdf"},{"key":"1187_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynecol Obstet 143:22\u201336. https:\/\/doi.org\/10.1002\/ijgo.12611","journal-title":"Int J Gynecol Obstet"},{"key":"1187_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Wallboomers","year":"1999","unstructured":"Wallboomers JM, Jacobs MV, Manos MM, Bosch FX, Shah KV (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199909)189:1%3c12:AID-PATH431%3e3.0.CO;2-F","journal-title":"J Pathol"},{"key":"1187_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctro.2018.01.001","volume":"9","author":"R P\u00f6tter","year":"2018","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B et al (2018) The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 9:48\u201360. https:\/\/doi.org\/10.1016\/j.ctro.2018.01.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"1187_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3892\/ijo_00000148","volume":"34","author":"R Munagala","year":"2009","unstructured":"Munagala R, Dona MG, Rai SN, Jenson AB, Bala N, Ghim SJ (2009) Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response. Int J Oncol 34:263\u2013271. https:\/\/doi.org\/10.3892\/ijo_00000148","journal-title":"Int J Oncol"},{"key":"1187_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00066-15-0909-0","volume":"192","author":"K Okuma","year":"2016","unstructured":"Okuma K, Yamashita H, Yokoyama T, Nakagawa K, Kawana K (2016) Undetected human papilloma virus DNA and uterine cervical carcinoma: association with cancer recurrence. Strahlenther Onkol 192:55\u201362. https:\/\/doi.org\/10.1007\/s00066-15-0909-0","journal-title":"Strahlenther Onkol"},{"key":"1187_CR8","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1002\/14651858.CD008285","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration (2008) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802\u20135812. https:\/\/doi.org\/10.1002\/14651858.CD008285","journal-title":"J Clin Oncol"},{"key":"1187_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","volume":"11","author":"AN Viswanathan","year":"2012","unstructured":"Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B (2012) American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 11:47\u201352. https:\/\/doi.org\/10.1016\/j.brachy.2011.07.002","journal-title":"Brachytherapy"},{"key":"1187_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"R Potter","year":"2005","unstructured":"Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M (2005) Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78:67\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2005.11.014","journal-title":"Radiother Oncol"},{"issue":"1","key":"1187_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/1471-0528.13071","volume":"122","author":"L Rodr\u00edguez-Carunchio","year":"2015","unstructured":"Rodr\u00edguez-Carunchio L, Soveral I, Steenbergen RDM, Torn\u00e9 A, Martinez S, Fust\u00e9 P, Pahisa J, Marimon L, Ordi J, Del Pino M (2015) HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis BJOG. Int J Obstet Gynaecol 122(1):119\u2013127. https:\/\/doi.org\/10.1111\/1471-0528.13071","journal-title":"Int J Obstet Gynaecol"},{"key":"1187_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ctrv.2015.11.008","volume":"42","author":"HW Wieringa","year":"2016","unstructured":"Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA (2016) Breaking the DNA damage response to improve cervical cancer treatment. Cancer Treat Rev 42:30\u201340. https:\/\/doi.org\/10.1016\/j.ctrv.2015.11.008","journal-title":"Cancer Treat Rev"},{"key":"1187_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048\u20131056. https:\/\/doi.org\/10.1016\/S1470-2045(10)70230-8","journal-title":"Lancet Oncol"},{"issue":"2","key":"1187_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canrad.2016.09.018","volume":"21","author":"P Moreno-Acosta","year":"2017","unstructured":"Moreno-Acosta P, Vallard A, Molano M, Huertas A, Gamboa \u00d3, Cotes M, Romero-Rojas A, Rancoule C, Magn\u00e9 N (2017) HPV-16 variants\u2019 impact on uterine cervical cancer response to radiotherapy: a descriptive pilot study. Cancer Radiother 21(2):104\u2013108. https:\/\/doi.org\/10.1016\/j.canrad.2016.09.018","journal-title":"Cancer Radiother"},{"key":"1187_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.meegid.2018.08.001","volume":"65","author":"S Kahla","year":"2018","unstructured":"Kahla S, Hammami S, Kochbati L, Chanoufi MB, Oueslati R (2018) HPV16 E2 variants correlated with radiotherapy treatment and biological significance in cervical cell carcinoma. Infect Genet Evol 65:238\u2013243. https:\/\/doi.org\/10.1016\/j.meegid.2018.08.001","journal-title":"Infect Genet Evol"},{"key":"1187_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00404-013-2803-2","volume":"288","author":"CL Barreto","year":"2013","unstructured":"Barreto CL, Martins DB, De Lima Filho JL, Magalhaes V (2013) Detection of human papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis. Arch Gynecol Obstet 288:643\u2013648. https:\/\/doi.org\/10.1007\/s00404-013-2803-2","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1187_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3892\/ol.2017.7327","volume":"15","author":"N Okonogi","year":"2018","unstructured":"Okonogi N, Kobayashi D, Suga T, Imai T, Wakatsuki M, Ohno T, Kato S, Nakano T, Kamada T (2018) Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer. Oncol Lett 15(1):459\u2013466. https:\/\/doi.org\/10.3892\/ol.2017.7327","journal-title":"Oncol Lett"},{"issue":"27","key":"1187_CR18","doi-asserted-by":"publisher","first-page":"18786","DOI":"10.18632\/oncotarget.24666","volume":"9","author":"M Kaliff","year":"2018","unstructured":"Kaliff M, Sorbe B, Mordhorst LB, Helenius G, Karlsson MG, Lillsunde-Larsson G (2018) Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy. Oncotarget 9(27):18786\u201318796. https:\/\/doi.org\/10.18632\/oncotarget.24666","journal-title":"Oncotarget"},{"key":"1187_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.ijrobp.2009.09.021","volume":"78","author":"CC Wang","year":"2010","unstructured":"Wang CC, Lai CH, Huang HJ, Chao A, Chang CJ, Chang TC, Chou HH, Hong JH (2010) Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy. Int J Radiat Oncol Biol Phys 78:1111\u20131120. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1187_CR20","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1200\/JCO.2004.09.035","volume":"22","author":"PW Grigsby","year":"2004","unstructured":"Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I (2004) Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 22:2167\u20132171. https:\/\/doi.org\/10.1200\/JCO.2004.09.035","journal-title":"J Clin Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-020-01187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-020-01187-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-020-01187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T23:46:38Z","timestamp":1618011998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-020-01187-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1007\/s11547-020-01187-x","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"type":"print","value":"0033-8362"},{"type":"electronic","value":"1826-6983"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The local ethics committee of the Health Science University approved this retrospective study, and informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical consent"}}]}}